U.S. SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                   FORM 10-QSB


(Mark One)

   [x]      Quarterly report under Section 13, or 15 (d) of the Securities
            Exchange Act of 1934

                 For the quarterly period ended October 31, 2005

   [ ]      Transition report under Section 13 or 15 (d) of the Exchange Act

               For the transition period from __________ to______


                         Commission file number 33-16335


                                   MALEX, INC.
        (Exact Name of Small Business Issuer as Specified in Its Charter)


                Delaware                                    75-2235008
   (State or Other Jurisdiction of                      (I.R.S. Employer
    Incorporation or Organization)                     Identification No.)

                18170 Hillcrest, Suite 100, Dallas, Texas, 75252
                    (Address of Principal Executive Offices)

                                 (972) 612 1400
                (Issuer's Telephone Number, Including Area Code)



              (Former Name, Former Address and Former Fiscal Year,
                          if Changed Since Last Report)


       Check whether the issuer:  (1) filed all reports  required to be filed by
Section 13 or 15(d) of the  Exchange  Act during the past 12 months (or for such
shorter period that the  registrant was required to file such reports),  and (2)
has been subject to such filing requirements for past 90 days. Yes No

                     APPLICABLE ONLY TO ISSUERS INVOLVED IN
                        BANKRUPTCY PROCEEDINGS DURING THE
                              PRECEDING FIVE YEARS

       Check whether the registrant  filed all documents and reports required to
be filed by Section 12, 13, or 15 (d) of the Exchange Act after the distribution
of securities under a plan confirmed by a court. Yes No

Indicate by check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Act) [x] Yes [] No

                      APPLICABLE ONLY TO CORPORATE ISSUERS

       State the number of shares outstanding of each of the issuer's classes of
common equity, as of the latest practicable date: 8,416,000

<PAGE>

                                   MALEX, INC.



                                    I N D E X



                                                                       Page No.

Part I         FINANCIAL INFORMATION:

          Item 1.   Condensed Balance Sheets (unaudited)                  3

                    Statements of Operations                              4

                    Statements of Cash Flows                              5

                    Notes to Financial Statements (unaudited)             6

          Item 2.   Management's Discussion and Analysis of Financial
                    Condition and Results of Operations                   6

Part II   OTHER INFORMATION                                               7







                                        2
<PAGE>

                                   MALEX, INC.
                          (a development stage company)

                          PART I. FINANCIAL INFORMATION


                            CONDENSED BALANCE SHEETS

                                   (Unaudited)

                                     ASSETS


                                          October 31, 2005    April 30, 2005
                                            (Unaudited)          (Audited)
                                             ---------          ----------


  Cash                                       $       3          $        3

Total Assets                                 $       3          $        3


                      LIABILITIES AND STOCKHOLDERS' EQUITY


Current Liabilities                          $   7,859          $    7,100

Stockholders' Equity:
  Common stock (number of
  shares authorized 75,000,000,
  issued and outstanding
  8,400,000 shares, par value
  $.00002/sh)                                      168                 168

Additional paid in capital                       2,097               2,097

Deficit accumulated during
   the development stage                       (10,121)             (9,362)
Stockholders Equity                             (7,856)             (7,097)

Total Liabilities &
Stockholders' Equity                         $       3          $        3





   The accompanying notes are an integral part of these financial statements.

                                        3
<PAGE>

                                   MALEX, INC.
                          (a development stage company)

                             STATEMENTS OF OPERATION

                                   (Unaudited)


                                      Six Months Ended    Six Months Ended
                                        October 31,         October 31,
                                            2005                2004
                                        -----------         -----------

Income                                  $      --           $      --


Expenses - General and
  Administrative                        $       759         $       950

Net Income (Loss)                       $      (759)        $      (950)

Earnings per common share*                        *                   *

*(less than $0.001 per
  share)

Weighted average number of
  shares outstanding                      8,416,000           8,416,000







                                        4
<PAGE>

                                   MALEX, INC.
                          (a development stage company)

                             STATEMENTS OF OPERATION

                                   (Unaudited)


                                    Three Months Ended   Three Months Ended
                                        October 31,          October 31,
                                            2005                 2004
                                        -----------          -----------


Income                                  $      --            $      --


Expenses - General and
  Administrative                        $      --            $      --

Net Income (Loss)                       $      --            $      --

Earnings per common share*                        *                    *

*(less than $0.001 per
  share)

Weighted average number of
  shares outstanding                      8,416,000            8,416,000












        The accompanying notes are an integral part of these statements.

                                        5
<PAGE>
<TABLE>
<CAPTION>

                                   MALEX, INC.
                          (a development stage company)

                            STATEMENTS OF CASH FLOWS

                                                 Six Months         Six Months
                                                    Ended              Ended
                                              October 31, 2005   October 31, 2004
                                              ----------------   ----------------
<S>                                           <C>                <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
  Net income (loss)                             $      (759)     $      (950)

ADJUSTMENTS TO RECONCILE NET GAIN (LOSS) TO
  NET CASH FROM OPERATING ACTIVITIES:
  Accounts payable and accrued expenses                 759              950

  Net cash used by operating activities                --               --

CASH FLOW FROM INVESTING ACTIVITIES:
     Net cash used by investing activities             --               --

CASH FLOW FROM FINANCING ACTIVITIES:
  Net cash provided by financing activities            --               --




NET INCREASE (DECREASE) IN CASH                        --               --

BEGINNING CASH BALANCE                                    3                3

CASH BALANCE AT END OF PERIOD                   $         3      $         3

</TABLE>





   The accompanying notes are an integral part of these financial statements.

                                        6
<PAGE>

                          NOTES TO FINANCIAL STATEMENTS
                                   (UNAUDITED)

Item 1.    Financial Statements

The accompanying unaudited financial statements have been prepared in accordance
with the instructions to Form 10-Q and do not include all of the information and
footnotes required by generally accepted accounting principles for complete
financial statements.

In the opinion of management, all adjustments (consisting of normal recurring
accruals) considered necessary for a fair presentation have been included. These
statements should be read in conjunction with the audited financial statements
and notes thereto included in the Registrant's Form 10-KSB for the year ended
April 30, 2005.

Item 2.    Management Discussion and Analysis of Financial Condition and Results
           of Operations

The period ended October 31, 2005 showed a loss of $(759) compared with
$(950)for the previous year.

Registrant has no operations or substantial assets and intends to seek out and
obtain candidates with which it can merge or whose operations or assets can be
acquired through the issuance of common stock and possibly debt.

It is the present expectation of the Management of Registrant that in connection
with any such merger or acquisition of operations or assets that the Management
of Registrant will be transferred to the new controlling shareholders. The
Management of Registrant intends to negotiate covenants with any such company or
controlling shareholders that it/they will maintain Registrant's registration
with the Securities and Exchange Commission, comply with the terms of its
Articles of Incorporation and Bylaws in all respects, maintain and promote an
orderly market in Registrant's Common Stock and otherwise treat Registrant's
shareholders fairly.

Liquidity and Capital Resources

Registrant is a development-stage company and has not conducted any business
operations as yet. The Registrant's cash resources and liquidity are extremely
limited. The Registrant has no assets to use as collateral to allow the
Registrant to borrow, and there is no available external funding source. If no
combination partner can be found within twelve months, Registrant will
experience severe cash flow difficulties. Registrant's principal needs for
capital are for Securities and Exchange Commission reporting requirements,
bookkeeping and professional fees.

Item 3.    Controls and Procedures

As of the end of the period covered by this quarterly report, our Chief
Executive Officer and Chief Financial Officer (the "Certifying Officer")
conducted evaluations of our disclosure controls and procedures. As defined
under Sections 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934
Act, as amended (the "Exchange Act") the term "disclosure controls and
procedures" means controls and other procedures of an issuer that are designed
to ensure that information required to be disclosed by the issuer in the reports
that it files or submits under the Exchange Act is recorded, processed,
summarized and reported, within the time periods specified in the SEC's rules
and forms. Disclosure controls and procedures include, without limitation,
controls and procedures designed to ensure that information required to be
disclosed by an issuer in the reports that it files or submits under the
Exchange Act is accumulated and communicated to the issuer 's management,
including the Certifying Officer, to allow timely decisions regarding required
disclosure. Based on this evaluation, the Certifying Officer has concluded that
our disclosure controls and procedures were effective to ensure that material
information is recorded, processed, summarized and reported by our management on
a timely basis in order to comply with our disclosure obligations under the
Exchange Act, and the rules and regulations promulgated thereunder.


                                        7
<PAGE>

                           PART II. OTHER INFORMATION

PART II - OTHER INFORMATION



Item 6.   Exhibits and Reports on Form 8-K

           31(1) Certification of Chief Executive Officer Pursuant to
                 Rule 13a-14(a) or Rule 15d-14(a).

           31(2) Certification of Chief Financial Officer Pursuant to
                 Rule 13a-14(a) or Rule 15d-14(a).

           32(1) Certification of Chief Executive Officer Pursuant to Rule
                 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350, as
                 Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of
                 2002.

           32(2) Certification of Chief Financial Officer Pursuant to Rule
                 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350, as
                 Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of
                 2002.

               (b)  Reports on Form 8-K
                      NONE



                                   SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereto duly authorized.



                                    MALEX, INC.
                                    (Registrant)



                                    By: /s/ Daniel Wettreich
                                       ---------------------------
                                       DANIEL WETTREICH, PRESIDENT


Date: December 13, 2005



                                        8